175 related articles for article (PubMed ID: 33235296)
1. Characterization of dysregulated glutamine metabolism in human glioma tissue with
Ekici S; Risk BB; Neill SG; Shu HK; Fleischer CC
Sci Rep; 2020 Nov; 10(1):20435. PubMed ID: 33235296
[TBL] [Abstract][Full Text] [Related]
2. Refined modelling of the short-T2 signal component and ensuing detection of glutamate and glutamine in short-TE, localised, (1) H MR spectra of human glioma measured at 3 T.
Gottschalk M; Troprès I; Lamalle L; Grand S; Le Bas JF; Segebarth C
NMR Biomed; 2016 Jul; 29(7):943-51. PubMed ID: 27197077
[TBL] [Abstract][Full Text] [Related]
3. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
4. Characterization of metabolites in infiltrating gliomas using ex vivo ¹H high-resolution magic angle spinning spectroscopy.
Elkhaled A; Jalbert L; Constantin A; Yoshihara HA; Phillips JJ; Molinaro AM; Chang SM; Nelson SJ
NMR Biomed; 2014 May; 27(5):578-93. PubMed ID: 24596146
[TBL] [Abstract][Full Text] [Related]
5. Optical biopsy identification and grading of gliomas using label-free visible resonance Raman spectroscopy.
Zhou Y; Liu CH; Wu B; Yu X; Cheng G; Zhu K; Wang K; Zhang C; Zhao M; Zong R; Zhang L; Shi L; Alfano RR
J Biomed Opt; 2019 Sep; 24(9):1-12. PubMed ID: 31512439
[TBL] [Abstract][Full Text] [Related]
6. A metabolomic data fusion approach to support gliomas grading.
Righi V; Cavallini N; Valentini A; Pinna G; Pavesi G; Rossi MC; Puzzolante A; Mucci A; Cocchi M
NMR Biomed; 2020 Mar; 33(3):e4234. PubMed ID: 31825557
[TBL] [Abstract][Full Text] [Related]
7. Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.
de la Fuente MI; Young RJ; Rubel J; Rosenblum M; Tisnado J; Briggs S; Arevalo-Perez J; Cross JR; Campos C; Straley K; Zhu D; Dong C; Thomas A; Omuro AA; Nolan CP; Pentsova E; Kaley TJ; Oh JH; Noeske R; Maher E; Choi C; Gutin PH; Holodny AI; Yen K; DeAngelis LM; Mellinghoff IK; Thakur SB
Neuro Oncol; 2016 Feb; 18(2):283-90. PubMed ID: 26691210
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiling of human gliomas assessed with NMR.
Lee JE; Jeun SS; Kim SH; Yoo CY; Baek HM; Yang SH
J Clin Neurosci; 2019 Oct; 68():275-280. PubMed ID: 31409545
[TBL] [Abstract][Full Text] [Related]
9. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
10. Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy.
Shao W; Gu J; Huang C; Liu D; Huang H; Huang Z; Lin Z; Yang W; Liu K; Lin D; Ji T
Mol Cancer; 2014 Aug; 13():197. PubMed ID: 25163530
[TBL] [Abstract][Full Text] [Related]
11. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
[TBL] [Abstract][Full Text] [Related]
12. Lack of choline elevation on proton magnetic resonance spectroscopy in grade I-III gliomas.
Chawla S; Lee SC; Mohan S; Wang S; Nasrallah M; Vossough A; Krejza J; Melhem ER; Nabavizadeh SA
Neuroradiol J; 2019 Aug; 32(4):250-258. PubMed ID: 31050313
[TBL] [Abstract][Full Text] [Related]
13. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
14. In vivo Metabolic Profiles as Determined by
Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U
Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683
[TBL] [Abstract][Full Text] [Related]
15. Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells.
Mesti T; Bouchemal N; Banissi C; Triba MN; Marbeuf-Gueye C; Cemazar M; Moyec LL; Carpentier AF; Savarin P; Ocvirk J
Radiol Oncol; 2018 Nov; 52(4):392-398. PubMed ID: 30511933
[TBL] [Abstract][Full Text] [Related]
16. MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas.
Stadlbauer A; Zimmermann M; Kitzwögerer M; Oberndorfer S; Rössler K; Dörfler A; Buchfelder M; Heinz G
Radiology; 2017 Jun; 283(3):799-809. PubMed ID: 27982759
[TBL] [Abstract][Full Text] [Related]
17. Expression of a gap junction protein, connexin43, in a large panel of human gliomas: new insights.
Crespin S; Fromont G; Wager M; Levillain P; Cronier L; Monvoisin A; Defamie N; Mesnil M
Cancer Med; 2016 Aug; 5(8):1742-52. PubMed ID: 27306693
[TBL] [Abstract][Full Text] [Related]
18. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.
Ziegler A; von Kienlin M; Décorps M; Rémy C
Cancer Res; 2001 Jul; 61(14):5595-600. PubMed ID: 11454713
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopic imaging of cerebral gliomas: correlation of metabolite ratios with histopathologic grading.
Hsu YY; Chang CN; Wie KJ; Lim KE; Hsu WC; Jung SM
Chang Gung Med J; 2004 Jun; 27(6):399-407. PubMed ID: 15455540
[TBL] [Abstract][Full Text] [Related]
20. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
